Pay in 4 interest-free payments of $5.11 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Rixa Health only works with state-licensed, accredited pharmacies that meet strict sterility and potency standards
5 Conclusion From the perspective of Chinese healthcare payers, our findings suggest that once-daily oral semaglutide as an add-on therapy is likely to be a more cost-effective option than most injectable GLP-1 RAs in China, excluding injectable semaglutide and exenatide, for patients with T2DM who have inadequate control on basal insulin
Alcohol should be avoided as it may contribute to dehydration and other gastroinstinals side effects
Follow-Up Guidance: Patients are advised on timing, storage, and handling of the medication
At 593 Days/~20 Months (N=40): Total 25.4 kg reduction from baseline (99.5 kg to 74.1 kg), BMI improved by 9.3 kg/m (from 36.5 to 27.2 kg/m), achieving 25.5% 2.4% total weight loss maintained entirely on generic AOMs without GLP-1 RA therapy
US$ 25.50
US$ 28.96
.png)
US$ 27.66
